ALTERED HEPATIC CATABOLISM OF LOW-DENSITY-LIPOPROTEIN SUBJECTED TO LIPID-PEROXIDATION IN-VITRO

被引:7
作者
STONE, WL
HEIMBERG, M
SCOTT, RL
LECLAIR, I
WILCOX, HG
机构
[1] UNIV TENNESSEE, HLTH SCI CTR, DEPT PHARMACOL, MEMPHIS, TN 38163 USA
[2] WASHINGTON UNIV, BARNES HOSP, DEPT INTERNAL MED, ST LOUIS, MO 63110 USA
关键词
D O I
10.1042/bj2970573
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Recent evidence suggests that oxidatively modified forms of low-density lipoprotein (LDL) may be particularly atherogenic. In this investigation, the catabolism of human LDL modified by lipid peroxidation in vitro was studied with a recirculating rat liver perfusion system. A dual-labelling technique was used that permitted native LDL and modified LDL to be studied simultaneously in the liver perfusion system. Native human LDL was found to have a fractional catabolic rate (FCR) of 1.00+/-0.21%/h, in agreement with other investigators. Subjecting LDL to oxidation for 12 h in the presence of 30 mu M FeEDTA. did not significantly affect its FCR. LDL treated with a superoxide-generating system (xanthine oxidase, hypoxanthine, O-2) in the presence of 30 mu M FeEDTA did, however, show a significant increase in FCR (3.23+/-0.19%/h). The hepatic uptakes of native LDL and LDL oxidized with FeEDTA + O-2 were similar, but both were significantly lower than the hepatic uptake of LDL treated with the superoxide-radical-generating system. The proteolysis of LDL with pancreatin did not influence either its susceptibility to oxidation or its FCR. LDL oxidation resulted in the preferential loss of alpha-tocopherol rather than gamma-tocopherol. These data indicate that the rat liver effectively catabolizes LDL oxidatively modified by treatment with the superoxide-generating system. Furthermore, our results suggest that only very low plasma levels of highly oxidized LDL could be found under conditions in vivo. The liver may therefore play a major role in protecting the arterial vasculature from highly atherogenic forms of LDL.
引用
收藏
页码:573 / 579
页数:7
相关论文
共 47 条
[1]   PRESENCE OF A MODIFIED LOW-DENSITY LIPOPROTEIN IN HUMANS [J].
AVOGARO, P ;
BON, GB ;
CAZZOLATO, G .
ARTERIOSCLEROSIS, 1988, 8 (01) :79-87
[2]   SIMULTANEOUS DETERMINATION OF ALPHA-TOCOPHEROL AND RETINOL IN PLASMA OR RED-CELLS BY HIGH-PRESSURE LIQUID-CHROMATOGRAPHY [J].
BIERI, JG ;
TOLLIVER, TJ ;
CATIGNANI, GL .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 1979, 32 (10) :2143-2149
[3]  
BOREL JP, 1985, CRC HDB METHODS OXYG, P410
[4]   HIGH-DENSITY-LIPOPROTEIN IS THE MAJOR CARRIER OF LIPID HYDROPEROXIDES IN HUMAN BLOOD-PLASMA FROM FASTING DONORS [J].
BOWRY, VW ;
STANLEY, KK ;
STOCKER, R .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (21) :10316-10320
[5]   THE SCAVENGER CELL PATHWAY FOR LIPOPROTEIN DEGRADATION - SPECIFICITY OF THE BINDING-SITE THAT MEDIATES THE UPTAKE OF NEGATIVELY-CHARGED LDL BY MACROPHAGES [J].
BROWN, MS ;
BASU, SK ;
FALCK, JR ;
HO, YK ;
GOLDSTEIN, JL .
JOURNAL OF SUPRAMOLECULAR STRUCTURE, 1980, 13 (01) :67-81
[6]   ANTIOXIDANTS AND ATHEROSCLEROSIS - A CURRENT ASSESSMENT [J].
CHISOLM, GM .
CLINICAL CARDIOLOGY, 1991, 14 (02) :25-30
[7]   XANTHINE-OXIDASE ACTIVITY IN MOUSE PANCREAS - EFFECTS OF CAERULEIN-INDUCED ACUTE-PANCREATITIS [J].
DEVENYI, ZJ ;
ORCHARD, JL ;
POWERS, RE .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1987, 149 (03) :841-845
[8]  
EDWARDS AL, 1979, MULTIPLE REGRESSION
[9]   ENDOGENOUS ANTIOXIDANTS AND LIPOPROTEIN OXIDATION [J].
ESTERBAUER, H ;
DIEBERROTHENEDER, M ;
WAEG, G ;
PUHL, H ;
TATZBER, F .
BIOCHEMICAL SOCIETY TRANSACTIONS, 1990, 18 (06) :1059-1061
[10]   MALONDIALDEHYDE ALTERATION OF LOW-DENSITY LIPOPROTEINS LEADS TO CHOLESTERYL ESTER ACCUMULATION IN HUMAN MONOCYTE-MACROPHAGES [J].
FOGELMAN, AM ;
SHECHTER, I ;
SEAGER, J ;
HOKOM, M ;
CHILD, JS ;
EDWARDS, PA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1980, 77 (04) :2214-2218